257 related articles for article (PubMed ID: 35479073)
21. [The diagnostic value of flow cytometry in patients with lymphoma associated hemophagocytic syndrome].
Zhang WL; Xu L; Zhang Q; Zhong FL; Dai J; Feng J; Sun LH; Xu HC; Xie WY; Zhang HY
Zhonghua Nei Ke Za Zhi; 2020 Dec; 59(12):976-981. PubMed ID: 33256339
[No Abstract] [Full Text] [Related]
22. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
23. Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome.
Yao S; Jin Z; He L; Zhang R; Liu M; Hua Z; Wang Z; Wang Y
Front Oncol; 2021; 11():788056. PubMed ID: 34938663
[TBL] [Abstract][Full Text] [Related]
24. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
[TBL] [Abstract][Full Text] [Related]
25. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
Liu JH; Liu W; Li YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
[TBL] [Abstract][Full Text] [Related]
26. Disparity Analysis of Clinical Features and Prognostic Evaluation of Hemophagocytic Lymphohistiocytosis in Pediatric and Adult Patients: A Retrospective Multicenter Study of 525 Cases in HHLWG.
Wang X; Zhou Y; Sun Q; Zhou H; Zhang Q; Shen Z; Huang J; Xue Y; Yan D; Fang Y; Sang W
Acta Haematol; 2023; 146(3):185-195. PubMed ID: 36623498
[TBL] [Abstract][Full Text] [Related]
27. [Clinical analyses of 80 hemophagocytic lymphohistiocytosis patients with Epstein-Barr viremia].
Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Li S; Tang R; Huang W; Chen J; Pei R; Wang Z
Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(36):2841-3. PubMed ID: 25534103
[TBL] [Abstract][Full Text] [Related]
28. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
[TBL] [Abstract][Full Text] [Related]
29. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis.
Song Y; Yin Q; Wang J; Wang Z
Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574
[TBL] [Abstract][Full Text] [Related]
30. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center.
Song Y; Wang J; Wang Y; Wang Z
Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452
[TBL] [Abstract][Full Text] [Related]
31. Clinical Significance of Plasma Soluble MICB in Children With EBV-associated Hemophagocytic Lymphohistiocytosis.
Wei A; Zhang L; Ma H; Cui L; Zhang Q; Wang D; Chen S; Du J; Zhao X; Wang T; Zhang R; Zheng H; Li Z
J Pediatr Hematol Oncol; 2023 May; 45(4):e446-e454. PubMed ID: 36898046
[TBL] [Abstract][Full Text] [Related]
32. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults.
Liu P; Pan X; Chen C; Niu T; Shuai X; Wang J; Chen X; Liu J; Guo Y; Xie L; Wu Y; Liu Y; Liu T
Blood; 2020 Mar; 135(11):826-833. PubMed ID: 31914172
[TBL] [Abstract][Full Text] [Related]
33. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children.
Cheng CN; Chu WY; Chang KC; Chen JS
J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
Jin Z; Wang Y; Wei N; Wang Z
Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
[TBL] [Abstract][Full Text] [Related]
36. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target.
Chuang HC; Lay JD; Hsieh WC; Su IJ
Cancer Sci; 2007 Sep; 98(9):1281-7. PubMed ID: 17627615
[TBL] [Abstract][Full Text] [Related]
37. Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis.
Xu L; Guo X; Guan H
Int J Lab Hematol; 2022 Feb; 44(1):74-81. PubMed ID: 34709704
[TBL] [Abstract][Full Text] [Related]
38. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors.
Park HS; Kim DY; Lee JH; Lee JH; Kim SD; Park YH; Lee JS; Kim BY; Jeon M; Kang YA; Lee YS; Seol M; Lee YJ; Lim YS; Jang S; Park CJ; Chi HS; Lee KH
Ann Hematol; 2012 Jun; 91(6):897-904. PubMed ID: 22147006
[TBL] [Abstract][Full Text] [Related]
39. [Clinical Characteristics and Prognostic Analysis of 59 Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Syndrome].
Zhou YL; Li F; Zhang RY; Chen ZW; Zhong N; Tang WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):657-662. PubMed ID: 32319412
[TBL] [Abstract][Full Text] [Related]
40. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
